Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function

Transplantation

Volumn 62, Issue 12, 1996, Pages 1811-1818

  Mcsherry, Cynthia ^a   Jackson, Annette ^a   Hertz, Marshall I ^a   Bolman III, R Morton ^a   Savik, Kay ^a   Reinsmoen, Nancy L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; CHIMERA; CLINICAL ARTICLE; CONFERENCE PAPER; FORCED EXPIRATORY VOLUME; HEART LUNG TRANSPLANTATION; HUMAN; HUMAN TISSUE; LUNG FUNCTION; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

BLOOD GROUPING AND CROSSMATCHING; BRONCHIOLITIS OBLITERANS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HLA-DR ANTIGENS; HUMANS; INCLUSION BODIES, VIRAL; LUNG; LUNG TRANSPLANTATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; TRANSPLANTATION CHIMERA;

EID: 0030471597     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612270-00023     Document Type: Conference Paper

References (43)

1. Richter N, Raddatz G, Graeter T, Schäfers H-J, Schlitt HJ. Allogeneic lymphocyte chimerism after clinical lung transplantation. Transplant Immunol 1995; 3: 74.
2. Richter N, Raddatz G, Steinhoff G, Schäfers H-J, Schlitt HJ. Transmission of donor lymphocytes in clinical lung transplantation. Transplant Int 1994; 7: 414.
3. Schlitt HJ, Kanehiro H, Raddatz G, et al. Persistence of donor lymphocytes in liver allograft recipients. Transplantation 1993; 56: 1001.
4. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
5. Starzl TE, Demetris AJ, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876.
6. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 1993; 328: 745.
7. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
8. Schlitt HJ, Hundrieser J, Hisanaga M, et al. Patterns of donor-type microchimerism after heart transplantation. Lancet 1994; 343: 1469.
9. McDaniel DO, Naftilan J, Hulvey K, et al. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 1994; 57: 852.
10. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151.
11. McSherry C, Hertz MI, Jackson AM, et al. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients. Clin Transplantation 1995; 9: 442.
12. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
13. Suberbielle C, Caillat-Zucman S, Legendre C, et al. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet 1994; 343: 1468.
14. Caillat-Zucman S, Legendre C, Suberbielle C, et al. Microchimerism frequency two to thirty years after cadaveric kidney transplantation. Hum Immunol 1994; 41: 91.
15. Schlitt HJ, Hundrieser J, Ringe B, Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 1994; 330: 646.
16. Rudert WA, Kocova M, Rao AS, Trucco M. Fine quantitation by competitive PCR of circulating donor cells in posttransplant chimeric recipients. Transplantation 1994; 58: 964.
17. Zeevi A, Pavlick M, Lombardozzi S, et al. Immune status of recipients following bone marrow-augmented solid organ transplantation. Transplantation 1995; 59: 616.
18. Schlitt HJ, Hundrieser J, Hisanaga M, et al. Donor-type microchimerism after heart transplantation - a dynamic process. Transplant Proc 1995; 27: 155.
19. Hisanaga M, Hundrieser J, Uthoff K, Wahlers T, Pichlmayr R, Schlitt HJ. Graft function and rejection patterns in heart-transplanted patients with and without systemic microchimerism. Transplant Proc 1995; 27: 202.
20. Hisanaga M, Hundrieser J, Böker K, et al. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation 1996; 61: 40.
21. Reinsmoen NL, Jackson A, McSherry C, et al. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation 1995; 60: 1546.
22. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15: 1.
23. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713.
24. Reinsmoen NL, Kaufman D, Matas A, Sutherland DER, Najarian JS, Bach FH. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Transplantation 1990; 50: 783.
25. Reinsmoen NL, Matas AJ. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1993; 55: 1017.
26. Reinsmoen NL, Bolman RM, Savik K, Butters K, Matas AJ, Hertz MI. Improved long-term graft outcome in lung transplant recipients who develop donor antigen-specific hyporeactivity. J Heart Lung Transplant 1994; 13: 30.
27. Reinsmoen NL, Bach FH. Cell typing: HTC-PLT (D, DR, SB). In: Heise E, ed. Cell immunology 1983. New York: AACHT, 1983: 66.
28. Reinsmoen NL, Bach FH. Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities. Hum Immunol 1986; 16: 329.
29. Ryder LP, Thomsen M, Platz P, Svejgaard A. Data reduction in LD-typing. In: Kissmeyer-Nielson F, ed. Histocompatibility testing 1975. Copenhagen: Munksgaard, 1975: 557.
30. Flomenberg N. Nomenclature for T-cell-defined HLA class II determinants. In: Dupont B, ed. Immunology of HLA. New York: Springer, 1989: 62.
31. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225.
32. Brisco MJ, Condon J, Sykes PJ, Neoh SH, Morley AA. Detection and quantitation of neoplastic cells in acute lymphoblastic leukemia, by use of the polymerase chain reaction. Br J Haematol 1991; 79: 211.
33. Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA. Quantitation of targets for PCR by use of limiting dilution. Biotechniques 1992; 13: 444.
34. Brisco MJ, Condon J, Hughes E, et al. Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet 1994; 343: 196.
35. Ouspenskaia MV, Johnston DA, Roberts WM, Estrov Z, Zipf TF. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia 1995; 9: 321.
36. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Leigh Brown AJ. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990; 64: 864.
37. Berry N, Ariyoshi K, Jobe O, et al. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 1994; 10: 1031.
38. Verhofstede C, Reniers S, Van Wanzeele F, Plum J. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease. AIDS 1994; 8: 1421.
39. Miller RG, Teh H-S, Harley E, Phillips RA. Quantitative studies of the activation of cytotoxic lymphocyte precursor cells. Immunol Rev 1977; 35: 38.
40. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. J Immunol 1981; 126: 1614.
41. Steinman RM, Inaba K, Austyn JM. Donor-derived chimerism in recipients of organ transplantation. Hepatology 1993; 17: 1153.
42. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13: 622.
43. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996; 93: 705.